Skip to main content
. 2023 May 2;7(14):3573–3581. doi: 10.1182/bloodadvances.2022009632

Table 3.

Multivariate analysis of post HSCT outcomes

Variable OS
RFS
Relapse
NRM
HR (95% CI) P HR (95% CI) P SHR (95% CI) P SHR (95% CI) P
Treatment
 IC without VEN Reference Reference Reference Reference
 LIT without VEN 1.10 (0.58-2.11) .76 1.04 (0.55-1.98) .90 1.97 (0.80-4.83) .14 0.50 (0.18-1.38) .18
 LIT with VEN 0.71 (0.35-1.43) .34 0.81 (0.42-1.56) .53 1.21 (0.49-3.00) .68 0.54 (0.20-1.43) .21
HCT-CI Score
 Low-/intermediate-risk (0-2) Reference Reference
 High-risk (≥3) 2.09 (1.20-3.65) .01 1.90 (1.11-3.25) .02